Publications

2024

• Atamjit Singh, Karanvir Singh, Kirandeep Kaur, Aman Sharma, Pallvi Mohana, Jignesh Prajapati, Uttam Kaur, Dweipayan Goswami, Saroj Arora, Renu Chadha, Preet Mohinder Singh Bedi. “Discovery of triazole tethered thymol/carvacrol-coumarin hybrids as new class of α-glucosidase inhibitors with potent in vivo antihyperglycemic activities” European Journal of Medicinal Chemistry, 263, 115948 (2024)
• Atamjit Singh, Karanvir Singh, Kamaljit Kaur, Amandeep Singh, Aman Sharma, Kirandeep Kaur, Jaskirat Kaur, Gurleen Kaur, Uttam Kaur, Harsimran Kaur, Prabhsimran Singh, Preet Mohinder Singh Bedi. “Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships.” Biomedicines 12 (6), 1192 (2024).

2023

• Atamjit Singh, Kirandeep Kaur, Pallvi Mohana, Karanvir Singh, Aman Sharma, Jignesh Prajapati, Dweipayan Goswami, Neha Khosla, Uttam Kaur, Rajanbir Kaur, Rajinder Kaur, Abhineet Rana, Sandeep Kour, Puja Ohri, Saroj Arora, Renu Chadha, Preet Mohinder Singh Bedi. “Development of thymol-isatin hybrids as broad-spectrum antibacterial agents with potent anti-MRSA activity.” RSC Medicinal Chemistry (2023).
• Atamjit Singh, Kirandeep Kaur, Harneetpal Kaur, Pallvi Mohana, Saroj Arora, Neena Bedi, Renu Chadha, and Preet Mohinder Singh Bedi. “Design, synthesis and biological evaluation of isatin-benzotriazole hybrids as new class of anti-Candida agents.” Journal of Molecular Structure1274: 134456 (2023).
• Atamjit Singh, Karanvir Singh, Aman Sharma, Sambhav Sharma, Kevin Batra, Kaustubh Joshi, Brahmjeet Singh, Kirandeep Kaur, Renu Chadha, and Preet Mohinder Singh Bedi. “Mechanistic insight and structure activity relationship of isatin-based derivatives in development of anti-breast cancer agents.” Molecular and Cellular Biochemistry: 1-34 (2023).
• Atamjit Singh, Karanvir Singh, Jashandeep Kaur, Ramanpreet Kaur, Aman Sharma, Jasleen Kaur, Uttam Kaur, Renu Chadha, and Preet Mohinder Singh Bedi. “Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential.” ACS Chemical Neuroscience (2023).
• Atamjit Singh, Karanvir Singh, Aman Sharma, Kirandeep Kaur, Renu Chadha, and Preet Mohinder Singh Bedi. “Past, Present and Future of Xanthine Oxidase Inhibitors: Design Strategies, Structural and Pharmacological Insights, Patents and Clinical Trials.” RSC Medicinal Chemistry 14, 2155-2191 (2023).
• Atamjit Singh, Karanvir Singh, Aman Sharma, Uttam Kaur, Kamaljit Kaur, Preet Mohinder Singh Bedi. “Recent Developments in 1,2,3-Triazole based α-Glucosidase Inhibitors: Design Strategies, Structure-activity Relationship and Mechanistic Insights” Chemistry & Biodiversity, e202401109 (2024).
• Atamjit Singh, Karanvir Singh, Aman Sharma, Komalpreet Kaur, Kirandeep Kaur, Renu Chadha, and Preet Mohinder Singh Bedi. “Recent developments in synthetic α-glucosidase inhibitors: A comprehensive review with structural and molecular insight.” Journal of Molecular Structure 135115, (2023).
• Atamjit Singh, Karanvir Singh, Aman Sharma, Kirandeep Kaur, Renu Chadha, and Preet Mohinder Singh Bedi. “Recent advances in antifungal drug development targeting lanosterol 14α‐demethylase (CYP51): A comprehensive review with structural and molecular insights.” Chemical Biology & Drug Design (2023).
• Atamjit Singh, Karanvir Singh, Aman Sharma, Jasleen Kaur, Ramanpreet Kaur, Jashandeep Kaur, Kirandeep Kaur, Renu Chadha, and Preet Mohinder Singh Bedi. “Rational utilization of 1, 2, 3-triazole scaffold in anti-MRSA drug development: Design strategies, Structural insights and Pharmacological outcomes.” Journal of Molecular Structure: 136557 (2023).
• Atamjit Singh, Karanvir Singh, Aman Sharma, Kaustubh Joshi, Brahmjeet Singh, Sambhav Sharma, Kevin Batra, Kirandeep Kaur, Dilpreet Singh, Renu Chadha, and Preet Mohinder Singh Bedi.”1, 2, 3‐triazole derivatives as an emerging scaffold for antifungal drug development against Candida albicans: A comprehensive review.” Chemistry & Biodiversity: e202300024, (2023).

2022

• Atamjit Singh, Harneetpal Kaur, Saroj Arora, Preet Mohinder Singh Bedi. Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents. Archiv der Pharmazie, 355(2), p.2100368 (2022).
• Atamjit Singh, Harpreet Kaur, Hasandeep Singh, Balbir Singh, Preet Mohinder Singh Bedi, and Sarabjit Kaur. “Ameliorative Effects of Grewia asiatica Leaves in Animal Models of Pain and Inflammation.” Journal of Herbs, Spices & Medicinal Plants (2022): 1-10.
• Atamjit Singh^#, Shilpa Heer, Komalpreet Kaur, Harmandeep Kaur Gulati, Nitish Kumar, Anchal Sharma, Jatinder Vir Singh, Kavita Bhagat, Gurinder Kaur, Kirandeep Kaur, Harbinder Singh, Renu Chadha, Preet Mohinder Singh Bedi. Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors. Archiv der Pharmazie, 355(2), e2200033 (2022).

2020

• Atamjit Singh, US Baghel, Manish Sinha, MS Ashawat. Quantitative Analysis of Rosuvastatin Calcium in Bulk and Solid Pharmaceutical Dosage Forms Using Green and Rapid Fourier-Transform Infrared Spectroscopic Method. Indian Journal of Pharmaceutical Sciences.82: 632-639 (2020).
• Atamjit Singh, Sahil Sharma, Saroj Arora, Shivani Attri, Prabhjot Kaur, Harmandeep Kaur Gulati, Kavita Bhagat, Nitish Kumar, Harbinder Singh, Jatinder Vir Singh, Preet Mohinder Singh Bedi. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation. Bioorganic & Medicinal Chemistry Letters. 30(20): 127477 (2020).
• Atamjit Singh, US Baghel, Manish Sinha, MS Ashawat. Quantitative Analysis of Rosuvastatin Calcium in Bulk and Solid Pharmaceutical Dosage Forms Using Green and Rapid Fourier-Transform Infrared Spectroscopic Method. Indian Journal of Pharmaceutical Sciences.82: 632-639 (2020).
• Atamjit Singh, Sahil Sharma, Saroj Arora, Shivani Attri, Prabhjot Kaur, Harmandeep Kaur Gulati, Kavita Bhagat, Nitish Kumar, Harbinder Singh, Jatinder Vir Singh, Preet Mohinder Singh Bedi. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation. Bioorganic & Medicinal Chemistry Letters. 30(20): 127477 (2020).
• Atamjit Singh^#, Gurvinder Singh, Preet Mohinder Singh Bedi. “Thiophene derivatives: A potent multitargeted pharmacological scaffold.” Journal of Heterocyclic Chemistry. 57: 2658-2703 (2020).

2019

• Atamjit Singh, Jatinder Vir Singh, Abhineet Rana, Kavita Bhagat, Harmandeep Kaur Gulati, Raman Kumar, Rajan Salwan, Kajal Bhagat, Gurinder Kaur, Navjot Singh, Randeep Kumar, Harbinder Singh, Sahil Sharma, Preet Mohinder Singh Bedi. Monocarbonyl curcumin-based molecular hybrids as potent antibacterial agents. ACS Omega. 4:11673-11684 (2019).